| Abstrakt: |
This study tended to clarify the role of miR‐126 in non‐small cell lung cancer (NSCLC) cell biological behaviors in vitro, containing cell proliferation, migration, invasion, and apoptosis. miRNA expression microarray related to NSCLC was accessed from gene expression omnibus (GEO) database and subjected to differential analysis using the "limma" package. Real‐time quantitative PCR was conducted to assess the expression of miR‐126 in NSCLC cell lines. wIn vitro experiments including 3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2‐H‐tetrazolium bromide (MTT), wound healing assay, Transwell, and flow cytometry assay were used for evaluating the effect of miR‐126 on cell proliferation, migration, invasion, and apoptosis. Additionally, target mRNA for miR‐126 was predicted and further validated by bioinformatics analysis and dual‐luciferase reporter assay, respectively. It suggested that miR‐126 was significantly down‐regulated in NSCLS based on the expression microarray, and similar expression trend was exhibited in cancer cell lines. In the meantime, overexpression of miR‐126 was found to result in inhibition of cell proliferation, migration, and invasion while promotion of cell apoptosis, with reductions in protein expression of AKT2 and phosphorylated HK2 (p‐HK2) as well. AKT2, identified to be a direct target of miR‐126 in NSCLC as judged by dual‐luciferase reporter assay. Additionally, overexpression of AKT2 was observed to have the ability of elevating p‐HK2 protein expression and reversing the effect of miR‐126 on NSCLC cell proliferation, migration, and invasion. Given the above findings, we can see that miR‐126 exerts its role in NSCLC cell proliferation, migration, invasion, and apoptosis with the aid of AKT2/HK2 axis. [ABSTRACT FROM AUTHOR] |
Plný text